Surmodics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$3.9Mgeneral payments (2019-2025)
$43Kresearch payments (2019-2025)
3,021clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $851K
2020 $293K
2021 $403K
2022 $497K
2023 $652K
2024 $618K
2025 $546K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Vascular Surgery $1.7M
Interventional Cardiology $1.3M
Cardiovascular Disease $519K
Vascular & Interventional Radiology $110K
Internal Medicine $76K
Pulmonary Disease $41K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Peter Schneider Honolulu, HI Vascular Surgery $1,475,369.00
Gary Ansel Columbus, OH Interventional Cardiology $843,226.11
Kenneth Rosenfield Boston, MA Cardiovascular Disease $438,609.91
Bruce Gray Greenville, SC Internal Medicine $68,417.88
Aloke Finn Baltimore, MD Interventional Cardiology $66,859.93
Lucas Ferrer Cardona San Antonio, TX Vascular Surgery $65,131.67
Ankur Lodha Lafayette, LA Interventional Cardiology $50,390.83
Pradeep Nair Houma, LA Interventional Cardiology $46,823.58
Nachiket Patel Mesa, AZ Interventional Cardiology $45,764.14
Dean Ferrera East Chicago, IN Interventional Cardiology $41,587.33

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.